DENTSPLY SIRONA Inc. (XRAY) Stake Lowered by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. trimmed its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 52.8% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,738,029 shares of the medical instruments supplier’s stock after selling 1,947,975 shares during the quarter. Epoch Investment Partners Inc. owned 0.76% of DENTSPLY SIRONA worth $103,951,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Alps Advisors Inc. increased its stake in DENTSPLY SIRONA by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 20 shares in the last quarter. Wetherby Asset Management Inc. increased its stake in DENTSPLY SIRONA by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 30 shares in the last quarter. BRYN MAWR TRUST Co increased its stake in DENTSPLY SIRONA by 0.5% during the 2nd quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock worth $782,000 after purchasing an additional 65 shares in the last quarter. Nordea Investment Management AB increased its stake in DENTSPLY SIRONA by 0.7% during the 2nd quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock worth $664,000 after purchasing an additional 75 shares in the last quarter. Finally, Security National Bank of Sioux City Iowa IA increased its stake in DENTSPLY SIRONA by 0.4% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock worth $1,497,000 after purchasing an additional 102 shares in the last quarter. 96.58% of the stock is owned by institutional investors and hedge funds.

XRAY has been the subject of a number of research reports. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, October 30th. HC Wainwright reissued a “buy” rating and set a $68.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, November 6th. Morgan Stanley reissued an “overweight” rating and set a $69.00 target price (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. BidaskClub cut DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Finally, TheStreet raised DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research note on Friday, November 3rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $67.73.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at $65.75 on Tuesday. DENTSPLY SIRONA Inc. has a 12-month low of $52.53 and a 12-month high of $68.98. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The firm has a market capitalization of $15,177.45, a P/E ratio of 26.33, a price-to-earnings-growth ratio of 2.62 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. During the same quarter in the prior year, the firm posted $0.66 EPS. The business’s revenue was up 5.8% on a year-over-year basis. sell-side analysts expect that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current year.

In related news, insider Mark Thierer acquired 77,000 shares of the business’s stock in a transaction dated Monday, November 13th. The stock was bought at an average price of $66.04 per share, with a total value of $5,085,080.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Nicholas W. Alexos acquired 50,000 shares of the business’s stock in a transaction dated Monday, November 13th. The stock was bought at an average cost of $65.85 per share, with a total value of $3,292,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.99% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Stake Lowered by Epoch Investment Partners Inc.” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/05/dentsply-sirona-inc-xray-stake-lowered-by-epoch-investment-partners-inc.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit